Stock MOLN MOLECULAR PARTNERS AG
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Molecular Partners AG

Equities

MOLN

CH0256379097

Delayed Swiss Exchange
Other stock markets
 10:19:07 2024-07-16 am EDT 		5-day change 1st Jan Change
5.86 CHF -0.17% Intraday chart for Molecular Partners AG -1.51% +70.35%
Jun. 20 Top Premarket Gainers MT
Jun. 17 Transcript : Molecular Partners AG Presents at TD Cowen 2nd Annual Radiopharmaceutical Innovation Summit, Jun-17-2024 10:40 AM

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Novocure Names Nicolas Leupin as Chief Medical Officer
MT
Molecular Partners' Chief Medical Officer to Step Down; Interim Successor Named
MT
Molecular Partners AG Announces Executive Changes
CI
Molecular Partners CFO To Leave By End-2022
MT
Molecular Partners AG Announces Executive Changes
CI
Molecular Partners Shareholders Vote to Re-Elect All Board Members
MT
Molecular Partners AG Announces Executive Changes
CI
Molecular Partners AG Announces Executive Changes
CI
Molecular Partners AG Announces Executive Changes, Effective July 1, 2019
CI
Molecular Partners AG Announces Management Appointments
CI
Molecular Partners AG Announces Board Changes
CI
Molecular Partners Approves the Election of William Burns as New Member of the Board of Directors and Vice-Chairman
CI
Bill Burns nominated for election to Molecular Partners’ Board of Directors as Vice-Chairman with nomination to Chairman in 2018
TE
Molecular Partners AG Announces Management Changes
CI
Patrick Amstutz Appointed as Chief Executive Officer
TE
Molecular Partners AG Announces Resignation of Christian Zahnd as Member of the Board of Directors
CI
Christian Zahnd appointed as Honorary Chairman of the Board of Directors as he decided not to stand for re-election as member of the Board of Directors at the Annual General Meeting 2017
TE
Molecular Partners AG to Propose Gwen Fyfe, MD for Election to Board of Directors
CI
Molecular Partners AG Announces Executive Changes
CI
Molecular Partners AG Appoints Dr. Andreas Harstrick as Chief Medical Officer and New Member of the Executive Management Team
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOLN Stock
  4. News Molecular Partners AG
  5. Insiders